TEVA(TEVA) - 2023 Q4 - Earnings Call Transcript

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2023 Earnings Conference Call January 31, 2024 8:00 AM ET Â Company Participants Richard Francis - President, Chief Executive Officer Eric Hughes - Executive Vice President, Global R&D, Chief Medical Officer Eli Kalif - Executive Vice President, Chief Financial Officer Ran Meir - Head of Investor Relations Conference Call Participants Glen Santangelo - Jefferies Ash Verma - UBS Jason Gerberry - Bank of America Umer Raffat - Evercore David Amsellem - Pipe ...